Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for Resected Stage II Melanoma Patients
NCT01264874Phase 3Terminated
- Sponsor
- European Institute of Oncology
- Start
- May 2010
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in melanoma, sponsored by European Institute of Oncology. Started May 2010; status: terminated.
02
Drugs
vitamin d
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01264874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264874.